查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1809856

生物製藥 TPE 管材市場按材料類型、管材類型、產品形態、功能等級、內徑/尺寸等級、尺寸標準、包裝、應用、最終用戶和分銷管道分類 - 全球預測 2025-2030

Biopharmaceutical TPE Tubing Market by Material Type, Tubing Type, Product Form, Functional Grade, Inner Diameter / Size Class, Size Specifications, Packaging, Application, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

生物製藥 TPE 管市場預計 2024 年將達到 22.5 億美元，2025 年將達到 24.1 億美元，2030 年將達到 34.9 億美元，複合年成長率為 7.61%。

主要市場統計數據
基準年2024年 22.5億美元
預計2025年 24.1億美元
預測年份 2030 34.9億美元
複合年成長率（%） 7.61%

生物製藥熱可塑性橡膠體管市場動態以及影響採購和使用的關鍵決定因素的策略概述

生物製藥產業越來越依賴高性能熱可塑性橡膠(TPE) 導管來支援生產、填充和分析工作流程中的無菌流體處理。本執行摘要概述了正在改變現代生物製程環境中導管解決方案採購和指定方式的技術、商業和監管主題。它重點關注材料性能、驗證要求、供應商可靠性以及影響上游、下游和支援設施選擇決策的營運權衡因素。

新材料創新、製造自動化和供應鏈彈性正在重新定義無菌生物加工環境中的管道選擇和驗證

材料科學、生產技術和監管環境的融合正在顯著改變生物製藥領域TPE導管的模式。新型聚合物共混物和配方正在提升其柔韌性、耐磨性和化學相容性，同時也為減少萃取物和提高滅菌相容性奠定了基礎。伴隨這些材料的進步，模具和擠出工藝也得到了改進，從而實現了更嚴格的公差、多腔幾何形狀和整合增強結構，以滿足現代泵系統和自動填充線的機械需求。

評估 2025 年美國關稅對零件採購、成本結構和認證計畫的綜合影響

2025年的關稅環境為依賴全球採購管材和成品零件的企業帶來了新的複雜性。聚合物原料、複合零件和部分成品的關稅調整正在改變到岸成本，並影響籌資策略。許多製造商和買家正在審查供應商合約、重新審視主供應協議，並重新調整庫存政策，以緩解關稅帶來的成本波動。

涵蓋材料配方、管材結構、產品展示、功能等級、尺寸類別和包裝策略的細粒度細分情報

穩健的細分框架能夠揭示差異化產品屬性如何轉化為規格、檢驗和採購路徑。依材料類型（聚烯彈性體、苯乙烯嵌段共聚物、熱塑性聚氨酯 (TPU) 和熱塑性硫化橡膠 (TPV)）進行評估時，每種聚合物系列都具有獨特的化學相容性、機械彈性和耐滅菌性，從而影響應用適用性和生物相容性測試要求。同樣，各種管材結構（編織增強型、多腔型和非增強型）也各自需要特定的性能特徵，例如壓力管理、抗扭結性以及清洗和可處置性。

各主要地區的業務運作和法規差異及其對供應連續性、資格認證途徑和商業可用性的影響

區域動態對供應連續性、監管預期以及管道組件採購的商業性考量有著巨大的影響。在美洲，高製造密度、靠近大型生物製藥叢集以及高度重視國內合格途徑，往往有利於縮短供應鏈並加快供應商回應時間。當有國內替代品可用時，這種環境可以加快認證週期，但也可能造成集中的需求壓力，需要強力的生產力計畫和合約透明度。

概況構成熱塑性管材生態系統的成熟製造商、技術專家和新興供應商的競爭定位

熱塑性導管供應商的特點是，既有全球知名的製造商，也有專注於聚合物化合物的製造商，以及提供利基或特定應用解決方案的小型創新企業。大型製造商通常憑藉經過驗證的技術資料集、全面的萃取物和可浸出物測試，以及支援快速轉換和序列化可追溯性的可擴展製造基地，脫穎而出。技術專家則專注於多腔設計、增強結構或專有化合物配方，以減少萃取物或提高低溫或高壓條件下的柔韌性。

為採購、工程和監管團隊提供可行的策略，以減輕干擾、最佳化檢驗並加速管道解決方案的部署

採購、工程和監管部門負責人應採取一系列協調一致的措施，以保持供應的連續性，加快資格確認，並最大限度地減少整體檢驗負擔。首先，優先考慮材料和架構的合理化，以減少需要全面資格確認的SKU數量。將材料和管材類型整合到少數檢驗的型號中，可以實現庫存管理的規模經濟，並減少導致生產延誤的變更控制事件的發生頻率。

結合主要相關人員訪談、技術文件審查和跨職能檢驗的強大調查方法確保了分析的嚴謹性和可重複性

分析採用混合方法研究途徑，旨在獲得可重複的、基於技術的洞察。主要輸入包括與供應鏈經理、驗證工程師和臨床營運負責人進行結構化訪談，並輔以聚合物規格、萃取物和可浸出物研究以及滅菌驗證報告等技術文件的審查。我們還進行了跨職能檢驗會議，以交叉比對供應商聲明與最終用戶體驗，並揭示在認證時間表和安裝程序方面存在的實際限制。

最終綜合涉及管道選擇、供應和合規的決策者的策略要點、風險狀況和優先舉措

材料創新、製造精度和不斷變化的貿易動態交織在一起，要求決策者採取整合策略規範、採購和認證連結起來。有效的導管策略始於一種嚴謹的細分方法，將材料化學、導管結構和產品展示與其支援的特定單元操作相匹配。這種匹配減少了不必要的認證範圍，並將測試資源引導至導管和製程之間最關鍵的介面。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章市場動態

  • 生物製藥灌裝表面處理工程對一次性 TPE 管材的需求不斷增加
  • 開發生物基 TPE 配方，以減少生物加工對環境的影響
  • 細胞治療應用中TPE管材的嚴格萃取物和可浸出測試通訊協定
  • TPE 管上的抗菌和防黏塗層可增強污染控制
  • 為高純度單劑量疫苗輸送系統客製化 TPE 管
  • 採用數位雙胞胎建模最佳化無菌條件下的TPE管性能
  • 監管協調推動生物製藥領域 TPE 管材的全球標準化
  • 擴大靈活的供應鏈夥伴關係，以緩解製造業的TPE樹脂短缺
  • TPE 管材的伽馬射線滅菌相容性的進步提高了無菌處理效率。
  • 連續製造的新興趨勢要求生物反應器採用高流量 TPE 管材設計

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第8章生物製藥TPE管材市場（依材料類型）

  • 聚烯彈性體
  • 苯乙烯基嵌段共聚物
  • 熱塑性聚氨酯（TPU）
  • 熱塑性硫化橡膠（TPV）

第9章生物製藥TPE管材市場（依管材類型）

  • 編織增強管
  • 多腔管
  • 非增強管

第 10 章。生物製藥 TPE 管材市場（依產品類型）

  • 散裝線圈和線軸
  • 預切長度
  • 無菌管組和歧管

第 11 章生物製藥 TPE 管材市場（依功能等級）

  • 通用輸送管
  • 高壓管
  • 泵浦級管材

第 12 章生物製藥 TPE 管材市場（以內徑 (ID)/尺寸等級）

  • 大直徑/轉移
  • 微流
  • 標準生物程序

第13章生物製藥TPE管材市場（依尺寸規格）

  • 內徑
    • 大的
    • 中等的
    • 微孔
    • 小的
  • 長度
    • 散裝卷材
    • 預切長度
  • 壁厚
    • 標準牆
    • 厚壁
    • 薄壁

第14章生物製藥TPE管材市場（依包裝）

  • 無塵室包裝
  • 伽瑪射線滅菌並雙層包裝
  • 非無菌散裝包裝
  • 預組裝無菌歧管

第15章生物製藥TPE管材市場（依應用）

  • 下游加工
    • 過濾和層析法
    • 收穫和澄清
  • 填充和整理
    • 無菌灌裝
    • 無菌取樣
  • 上游處理
    • 培養基和緩衝液的製備
    • 種子列車和生物反應器
  • 公用事業和交通
    • 蠕動幫浦
    • 儲存和冷藏
    • 轉讓和分配

第16章生物製藥TPE管材市場（依最終用戶）

  • 學術研究機構
  • 生物製藥和生物技術製造商
    • 新興生技公司
    • 大型製藥公司
  • 細胞和基因治療開發商
  • 臨床和診斷實驗室
  • 契約製造組織（CMO）

第17章生物製藥TPE管材市場（依通路）

  • 直銷
  • 分銷商和批發商
  • 線上管道

18.美洲生物製藥TPE管材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

19. 歐洲、中東和非洲生物製藥TPE管市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

20. 亞太生物製藥TPE管材市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第21章 競爭態勢

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • DuPont de Nemours, Inc.
    • Compagnie de Saint-Gobain
    • Avantor, Inc.
    • Avient Corporation
    • BiomatiQ Scientific Pvt. Ltd.
    • Eldon James Corporation
    • Entegris, Inc.
    • FOXX Life science
    • Freudenberg Medical, LLC.
    • IDEX Health & Science LLC
    • Medline Industries, LP
    • Meridian Industries, Inc
    • NewAge Industries
    • Nordson Corporation
    • Optinova Holding Ab
    • Qosina Corp.
    • Raumedic AG by REHAU Group
    • SaniSure
    • Seisa Group, Inc.
    • TE Connectivity Ltd.
    • Tekni-Plex, Inc.
    • Thermo Fisher Scientific Inc.
    • WL Gore & Associates, Inc.
    • Watson-Marlow Fluid Technology Group
    • WHK BioSystemss, LLC.

第22章 研究人工智慧

第23章 研究統計

第24章 研究聯絡人

第25章 研究報導

第26章 附錄

Product Code: MRR-5319A8C1C3D6

The Biopharmaceutical TPE Tubing Market was valued at USD 2.25 billion in 2024 and is projected to grow to USD 2.41 billion in 2025, with a CAGR of 7.61%, reaching USD 3.49 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.25 billion
Estimated Year [2025] USD 2.41 billion
Forecast Year [2030] USD 3.49 billion
CAGR (%) 7.61%

Strategic overview of biopharmaceutical thermoplastic elastomer tubing market dynamics and critical determinants shaping procurement and use

The biopharmaceutical sector increasingly depends on high-performance thermoplastic elastomer (TPE) tubing to support sterile fluid handling across production, fill-finish, and analytical workflows. This executive summary synthesizes the technical, commercial, and regulatory themes that are reshaping procurement and specification of tubing solutions used in modern bioprocess environments. It emphasizes material performance, validation requirements, supplier reliability, and the operational trade-offs that drive selection decisions across upstream, downstream, and support utilities.

Across manufacturing facilities and contract operations, tubing is no longer a simple passive conduit; it interfaces directly with process-critical steps such as media preparation, peristaltic pumping, filtration, chromatography, and aseptic filling. As such, engineering, quality, and procurement stakeholders require integrated analysis that connects polymer chemistry and tubing architecture to sterilization pathways, extractables and leachables behavior, and qualification burden. The sections that follow outline the technological inflections, policy impacts, segmentation insights, regional contrasts, and recommended actions designed to help leaders make informed, defensible choices while maintaining supply resilience and regulatory compliance.

This introduction sets the stage for a detailed examination of recent material innovations, supply chain pressures, tariff-driven adjustments, and strategic supplier positioning that together define the contemporary tubing landscape for life sciences organizations.

Emerging material innovations, manufacturing automation, and supply chain resilience redefining tubing selection and validation in sterile bioprocessing environments

The landscape for TPE tubing in biopharmaceutical applications is undergoing transformative shifts driven by converging forces in materials science, production engineering, and regulatory expectations. Novel polymer blends and compound formulations are improving flexibility, abrasion resistance, and chemical compatibility while offering pathways to lower extractables and enhanced sterilization compatibility. These material advances are paralleled by tooling and extrusion process improvements that enable tighter tolerances, multi-lumen geometries, and integrated reinforcement structures that meet the mechanical demands of modern pumping systems and automated filling lines.

At the same time, automation and digital traceability are becoming standard differentiators. Manufacturers are embedding serialized identifiers, batch-level documentation, and manufacturing execution system integrations to support lot tracking, change control, and faster release testing. This evolution reduces the administrative friction associated with bringing new tubing into validated processes and improves recall readiness and supplier accountability.

Supply chain dynamics are also shifting: onshoring and dual-sourcing strategies are gaining traction in response to geopolitical risk and heightened demand volatility. This change is accompanied by tighter regulatory scrutiny around material provenance and sterilization validation. Consequently, buyers are prioritizing suppliers who can demonstrate robust quality systems, transparent material supply chains, and evidence-based compatibility assessments. Taken together, these shifts are making tubing procurement a strategic activity that directly influences process robustness, product integrity, and commercialization timelines.

Assessment of United States tariff measures enacted in 2025 and their compound effects on component sourcing, cost structures, and qualification timelines

The tariff environment introduced in 2025 has introduced a new layer of complexity for organizations that rely on globally sourced tubing materials and finished components. Tariff adjustments on polymer feedstocks, compounded components, and select finished goods have changed landed costs and influenced sourcing strategies. Many manufacturers and buyers are reassessing vendor agreements, reconsidering master supply contracts, and recalibrating inventory policies to mitigate tariff-driven cost volatility.

Operationally, tariffs have accelerated conversations about nearshoring and qualifying domestic supply partners to reduce exposure to cross-border duties and logistics disruptions. Facilities with localized qualification programs are better positioned to pivot suppliers without incurring prolonged validation cycles, whereas organizations dependent on single-source offshore suppliers face greater risk of production interruptions and extended lead times. In addition, increased documentation requirements related to origin declarations and classification codes have elevated the administrative burden on procurement and quality teams.

To navigate these changes, technical and commercial stakeholders are adopting more granular costing models that incorporate tariff scenarios into total landed cost calculations, without relying solely on price per unit. They are also enhancing supplier scorecards to include duty exposure, tariff classification transparency, and responsiveness to certificate and test-report requests. These adjustments aim to protect continuity of supply and preserve validation timelines while managing the financial and operational consequences of the 2025 tariff landscape.

Granular segmentation intelligence covering material formulations, tubing architectures, product presentation, functional grades, dimensional classes, and packaging strategies

A robust segmentation framework reveals how differentiated product attributes translate into distinct specification, validation, and procurement pathways. When evaluated by material type-covering polyolefin elastomers, styrenic block copolymers, thermoplastic polyurethane (TPU), and thermoplastic vulcanizates (TPV)-each polymer family presents a unique profile of chemical compatibility, mechanical resilience, and sterilization tolerance that influences application suitability and biocompatibility testing requirements. Likewise, tubing architecture spans braided reinforced tubing, multi-lumen tubing, and non-reinforced tubing, each of which imposes specific performance expectations for pressure management, kinking resistance, and cleaning or single-use disposal practices.

Product form is another key discriminator: options such as bulk coils and spools, pre-cut lengths, and sterile tubing sets and manifolds dictate downstream handling, inventory strategies, and cleanroom integration procedures. Functional grade segmentation into general transfer tubing, high-pressure tubing, and pump grade tubing further differentiates qualification scope because each grade requires tailored mechanical and chemical testing to validate performance under intended use conditions. Dimensional classes based on inner diameter and size-spanning large-bore transfer, micro-flow, and standard bioprocess sizes-affect flow dynamics, dead volume considerations, and compatibility with fittings and peristaltic pump heads. In parallel, size specifications such as inner diameter categories (large, medium, microbore, small), length formats (bulk coils versus pre-cut lengths), and wall thickness variants (standard, thick wall, thin wall) create downstream routine decisions related to inventory control, sterility assurance, and process integration.

Packaging choices ranging from cleanroom packaged, gamma-sterilized double-bagged, non-sterile bulk packaging, to pre-assembled sterile manifolds influence time-to-use, validation burden for sterile operations, and the frequency of reprocessing or discarding. Applications across downstream processing, fill-finish, upstream processing, and utilities and transfer-including subdomains such as filtration and chromatography, aseptic filling, media and buffer preparation, and peristaltic pumping-demand explicit mapping between tubing specifications and unit operations. Finally, end users from academic and research institutes to biopharma and biotech manufacturers, cell and gene therapy developers, clinical laboratories, and contract manufacturing organizations exhibit distinct procurement behaviors and validation tolerances, while distribution channels-direct sales, distributors and wholesalers, and online channels-shape lead times and contractual flexibility. Integrating these segmentation vectors enables buyers and specifiers to align technical performance with operational realities and prioritize qualification activities that deliver the highest operational return.

Regional operational and regulatory contrasts across major geographies and their implications for supply continuity, qualification pathways, and commercial access

Regional dynamics exert a powerful influence on supply continuity, regulatory expectations, and the commercial calculus for sourcing tubing components. In the Americas, manufacturing density, proximity to large biopharma clusters, and an emphasis on domestic qualification pathways tend to favor shorter supply chains and faster supplier responsiveness. This environment accelerates qualification cycles when domestic alternatives are available, but it can also concentrate demand pressures that require robust capacity planning and contract visibility.

Across Europe, Middle East & Africa, regulatory harmonization within major markets is juxtaposed with diverse national requirements that affect sterilization validation, material declarations, and import controls. Buyers in this region must balance regional regulatory consistency against localized documentation demands and language-specific compliance materials. In addition, the presence of specialized suppliers and advanced manufacturing hubs offers opportunities for collaborative development but may require longer lead times for custom formulations or multi-lumen architectures.

In Asia-Pacific, a combination of large-scale polymer production, specialized extruders, and rapidly evolving life sciences clusters shapes competitive supplier offerings. Organizations sourcing from this region benefit from manufacturing breadth and cost-competitive options; however, they must also manage longer logistics lead times, potential classification variances, and geopolitical sensitivities that may affect export controls. Across all regions, buyers should assess regional strengths against internal capabilities for qualification and inventory buffering, and then align sourcing strategies to balance cost, lead time, and risk tolerance.

Competitive positioning overview highlighting incumbent manufacturers, technology specialists, and emerging suppliers shaping the thermoplastic tubing ecosystem

Supplier landscapes for thermoplastic tubing are characterized by a mix of global incumbents, specialized polymer compounders, and smaller innovators delivering niche or application-specific solutions. Leading manufacturers typically differentiate through validated technical datasets, comprehensive extractables and leachables testing, and scalable manufacturing footprints that support rapid changeover and serialized traceability. Technology specialists focus on multi-lumen designs, reinforced constructions, or proprietary compound recipes that reduce extractables or improve flexibility under cryogenic or high-pressure conditions.

Newer entrants and regionally focused suppliers often compete on rapid customization, localized inventory, and flexible packaging options that suit single-use assemblies or pre-sterilized manifold systems. Their agility can be an advantage for clinical-scale programs and early-stage developers, but buyers must weigh that agility against the depth of documented quality systems and historical supply performance.

From a commercial perspective, strategic suppliers offer collaboration on specification rationalization, co-development of sterilization protocols, and joint risk-sharing arrangements to streamline qualification. They also increasingly provide digital assets such as test certificates, traceability records, and compatibility matrices to integrate with customers' quality management systems. Organizations should assess supplier capabilities across technical validation support, regulatory documentation responsiveness, manufacturing redundancies, and the ability to deliver consistent packaging and sterilization formats to minimize downstream qualification friction.

Actionable strategies for procurement, engineering, and regulatory teams to mitigate disruption, optimize validation, and accelerate deployment of tubing solutions

Leaders in procurement, engineering, and regulatory affairs should adopt a coordinated set of actions to preserve supply continuity, accelerate qualification, and minimize total validation burden. First, prioritize material and architecture rationalization to reduce the number of unique SKUs that require full qualification. Consolidating around a small set of validated materials and tubing types enables economies of scale in inventory management and reduces the frequency of change control events that can delay production.

Second, establish dual-source strategies that pair a primary supplier with a validated secondary capable of matching certificates and testing profiles. When paired with pre-approved technical equivalency criteria, dual sourcing can mitigate single-point-of-failure risk without triggering extensive retesting. Third, invest in supplier data integration: require structured delivery of certificates of analysis, extractables and leachables reports, and sterilization validation packages in machine-readable formats to speed internal review and release processes. Fourth, align packaging strategies with operational readiness by specifying sterile pre-assembled options for critical aseptic operations and reserving non-sterile bulk formats for low-risk transfer tasks. Finally, incorporate tariff and trade-risk assessments into vendor selection criteria and contractual terms to reduce unexpected cost exposure and administrative burden during classification disputes or duty changes. These practical steps, when implemented together, create a resilient procurement posture that balances technical rigor with commercial agility.

Robust research approach integrating primary stakeholder interviews, technical dossier review, and cross-functional validation to ensure analytical rigor and reproducibility

This analysis relied on a mixed-methods research approach designed to produce reproducible, technically grounded insights. Primary inputs included structured interviews with supply chain managers, validation engineers, and clinical operations leaders, supplemented by technical dossier reviews of polymer specifications, extractables and leachables studies, and sterilization validation reports. Cross-functional validation sessions were conducted to reconcile supplier claims with end-user experiences, and to surface practical constraints in qualification timelines and installation procedures.

Secondary review incorporated manufacturing process documentation, industry guidance on biocompatibility and sterilization, and regulatory frameworks relevant to sterile fluid contact components. Where possible, triangulation across different data sources was used to confirm material behavior under typical process stressors, such as peristaltic compression cycles, high-pressure filtration, and repeated sterilization exposures. The methodology emphasized traceability and auditability of evidence, ensuring that recommendations are supported by both technical test outcomes and operational use cases.

Quality controls included reviewer cross-checks, source reliability assessments, and explicit documentation of assumptions and inclusion criteria for supplier data. This structured approach ensures that conclusions and recommended actions maintain a direct line to observable performance characteristics and stakeholder-validated practices in commercial and clinical manufacturing settings.

Conclusive synthesis of strategic takeaways, risk contours, and priority initiatives for decision-makers navigating tubing selection, supply, and compliance

In synthesis, the confluence of material innovation, manufacturing precision, and evolving trade dynamics requires decision-makers to adopt integrated strategies that link specification, sourcing, and qualification. Effective tubing strategies begin with a disciplined segmentation approach that aligns material chemistry, tubing architecture, and product presentation to the specific unit operations they support. This alignment reduces unnecessary qualification scope and directs testing resources to the highest-impact interfaces between tubing and process.

Risk management is equally important: organizations that combine supplier diversification, localized qualification capabilities, and digital documentation flows are better able to absorb supply disruptions and tariff-related cost shifts. Technical due diligence-grounded in extractables and leachables science, sterilization compatibility, and mechanical performance testing-remains central to preserving product quality and regulatory compliance. At the same time, operational choices around packaging, length formats, and pre-assembled manifolds can materially shorten time-to-use for critical sterile operations.

Ultimately, success depends on cross-functional collaboration across procurement, quality, and process engineering, supported by supplier partners who provide transparent data and agile manufacturing capabilities. By translating the analytical findings in this report into practical validation roadmaps and contract mechanisms, organizations can achieve robust supply continuity while maintaining the technical rigor required for modern biopharmaceutical production.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Increasing demand for single-use TPE tubing in biopharmaceutical fill-finish processes
  • 5.2. Development of bio-based TPE formulations to reduce environmental impact in bioprocessing operations
  • 5.3. Stringent extractables and leachables testing protocols for TPE tubing in cell therapy applications
  • 5.4. Integration of antimicrobial and anti-adhesive coatings on TPE tubing for enhanced contamination control
  • 5.5. Customization of TPE tubing for high-purity single-dose vaccine delivery systems
  • 5.6. Adoption of digital twin modeling for optimization of TPE tubing performance under sterile conditions
  • 5.7. Regulatory harmonization driving global standardization of TPE tubing materials in biopharma
  • 5.8. Expansion of flexible supply chain partnerships to mitigate TPE resin shortages in manufacturing
  • 5.9. Advancements in gamma sterilization compatibility of TPE tubing for aseptic processing efficiency
  • 5.10. Emerging trends in continuous manufacturing necessitating high-flow TPE tubing designs for bioreactors

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Biopharmaceutical TPE Tubing Market, by Material Type

  • 8.1. Introduction
  • 8.2. Polyolefin Elastomers
  • 8.3. Styrenic Block Copolymers
  • 8.4. Thermoplastic Polyurethane (TPU)
  • 8.5. Thermoplastic Vulcanizates (TPV)

9. Biopharmaceutical TPE Tubing Market, by Tubing Type

  • 9.1. Introduction
  • 9.2. Braided Reinforced Tubing
  • 9.3. Multi-Lumen Tubing
  • 9.4. Non-Reinforced Tubing

10. Biopharmaceutical TPE Tubing Market, by Product Form

  • 10.1. Introduction
  • 10.2. Bulk Coils & Spools
  • 10.3. Pre-Cut Lengths
  • 10.4. Sterile Tubing Sets & Manifolds

11. Biopharmaceutical TPE Tubing Market, by Functional Grade

  • 11.1. Introduction
  • 11.2. General Transfer Tubing
  • 11.3. High-Pressure Tubing
  • 11.4. Pump Grade Tubing

12. Biopharmaceutical TPE Tubing Market, by Inner Diameter (ID) / Size Class

  • 12.1. Introduction
  • 12.2. Large-bore/transfer
  • 12.3. Micro-flow
  • 12.4. Standard Bioprocess

13. Biopharmaceutical TPE Tubing Market, by Size Specifications

  • 13.1. Introduction
  • 13.2. Inner Diameter
    • 13.2.1. Large
    • 13.2.2. Medium
    • 13.2.3. Microbore
    • 13.2.4. Small
  • 13.3. Length
    • 13.3.1. Bulk Coils
    • 13.3.2. Pre-Cut Lengths
  • 13.4. Wall Thickness
    • 13.4.1. Standard Wall
    • 13.4.2. Thick Wall
    • 13.4.3. Thin Wall

14. Biopharmaceutical TPE Tubing Market, by Packaging

  • 14.1. Introduction
  • 14.2. Cleanroom Packaged
  • 14.3. Gamma-Sterilized Double-Bagged
  • 14.4. Non-Sterile Bulk Packaging
  • 14.5. Pre-Assembled Sterile Manifolds

15. Biopharmaceutical TPE Tubing Market, by Application

  • 15.1. Introduction
  • 15.2. Downstream Processing
    • 15.2.1. Filtration & Chromatography
    • 15.2.2. Harvest & Clarification
  • 15.3. Fill-Finish
    • 15.3.1. Aseptic Filling
    • 15.3.2. Sterile Sampling
  • 15.4. Upstream Processing
    • 15.4.1. Media & Buffer Preparation
    • 15.4.2. Seed Train & Bioreactors
  • 15.5. Utilities & Transfer
    • 15.5.1. Peristaltic Pumping
    • 15.5.2. Storage & Freezing
    • 15.5.3. Transfer & Distribution

16. Biopharmaceutical TPE Tubing Market, by End User

  • 16.1. Introduction
  • 16.2. Academic & Research Institutes
  • 16.3. Biopharma & Biotech Manufacturers
    • 16.3.1. Emerging Biotech Firms
    • 16.3.2. Large Pharmaceutical Companies
  • 16.4. Cell & Gene Therapy Developers
  • 16.5. Clinical & Diagnostic Laboratories
  • 16.6. Contract Manufacturing Organizations (CMOs)

17. Biopharmaceutical TPE Tubing Market, by Distribution Channel

  • 17.1. Introduction
  • 17.2. Direct Sales
  • 17.3. Distributors & Wholesalers
  • 17.4. Online Channels

18. Americas Biopharmaceutical TPE Tubing Market

  • 18.1. Introduction
  • 18.2. United States
  • 18.3. Canada
  • 18.4. Mexico
  • 18.5. Brazil
  • 18.6. Argentina

19. Europe, Middle East & Africa Biopharmaceutical TPE Tubing Market

  • 19.1. Introduction
  • 19.2. United Kingdom
  • 19.3. Germany
  • 19.4. France
  • 19.5. Russia
  • 19.6. Italy
  • 19.7. Spain
  • 19.8. United Arab Emirates
  • 19.9. Saudi Arabia
  • 19.10. South Africa
  • 19.11. Denmark
  • 19.12. Netherlands
  • 19.13. Qatar
  • 19.14. Finland
  • 19.15. Sweden
  • 19.16. Nigeria
  • 19.17. Egypt
  • 19.18. Turkey
  • 19.19. Israel
  • 19.20. Norway
  • 19.21. Poland
  • 19.22. Switzerland

20. Asia-Pacific Biopharmaceutical TPE Tubing Market

  • 20.1. Introduction
  • 20.2. China
  • 20.3. India
  • 20.4. Japan
  • 20.5. Australia
  • 20.6. South Korea
  • 20.7. Indonesia
  • 20.8. Thailand
  • 20.9. Philippines
  • 20.10. Malaysia
  • 20.11. Singapore
  • 20.12. Vietnam
  • 20.13. Taiwan

21. Competitive Landscape

  • 21.1. Market Share Analysis, 2024
  • 21.2. FPNV Positioning Matrix, 2024
  • 21.3. Competitive Analysis
    • 21.3.1. DuPont de Nemours, Inc.
    • 21.3.2. Compagnie de Saint-Gobain
    • 21.3.3. Avantor, Inc.
    • 21.3.4. Avient Corporation
    • 21.3.5. BiomatiQ Scientific Pvt. Ltd.
    • 21.3.6. Eldon James Corporation
    • 21.3.7. Entegris, Inc.
    • 21.3.8. FOXX Life science
    • 21.3.9. Freudenberg Medical, LLC.
    • 21.3.10. IDEX Health & Science LLC
    • 21.3.11. Medline Industries, LP
    • 21.3.12. Meridian Industries, Inc
    • 21.3.13. NewAge Industries
    • 21.3.14. Nordson Corporation
    • 21.3.15. Optinova Holding Ab
    • 21.3.16. Qosina Corp.
    • 21.3.17. Raumedic AG by REHAU Group
    • 21.3.18. SaniSure
    • 21.3.19. Seisa Group, Inc.
    • 21.3.20. TE Connectivity Ltd.
    • 21.3.21. Tekni-Plex, Inc.
    • 21.3.22. Thermo Fisher Scientific Inc.
    • 21.3.23. W. L. Gore & Associates, Inc.
    • 21.3.24. Watson-Marlow Fluid Technology Group
    • 21.3.25. WHK BioSystemss, LLC.

22. ResearchAI

23. ResearchStatistics

24. ResearchContacts

25. ResearchArticles

26. Appendix

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL TPE TUBING MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TUBING TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TUBING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FUNCTIONAL GRADE, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FUNCTIONAL GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER (ID) / SIZE CLASS, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER (ID) / SIZE CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SIZE SPECIFICATIONS, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SIZE SPECIFICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 20. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 22. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 24. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 28. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 30. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 31. ASIA-PACIFIC BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 32. ASIA-PACIFIC BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 33. BIOPHARMACEUTICAL TPE TUBING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. BIOPHARMACEUTICAL TPE TUBING MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 35. BIOPHARMACEUTICAL TPE TUBING MARKET: RESEARCHAI
  • FIGURE 36. BIOPHARMACEUTICAL TPE TUBING MARKET: RESEARCHSTATISTICS
  • FIGURE 37. BIOPHARMACEUTICAL TPE TUBING MARKET: RESEARCHCONTACTS
  • FIGURE 38. BIOPHARMACEUTICAL TPE TUBING MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL TPE TUBING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY POLYOLEFIN ELASTOMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY POLYOLEFIN ELASTOMERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STYRENIC BLOCK COPOLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STYRENIC BLOCK COPOLYMERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY THERMOPLASTIC POLYURETHANE (TPU), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY THERMOPLASTIC POLYURETHANE (TPU), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY THERMOPLASTIC VULCANIZATES (TPV), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY THERMOPLASTIC VULCANIZATES (TPV), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TUBING TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TUBING TYPE, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BRAIDED REINFORCED TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BRAIDED REINFORCED TUBING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MULTI-LUMEN TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MULTI-LUMEN TUBING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY NON-REINFORCED TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY NON-REINFORCED TUBING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BULK COILS & SPOOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BULK COILS & SPOOLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRE-CUT LENGTHS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRE-CUT LENGTHS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STERILE TUBING SETS & MANIFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STERILE TUBING SETS & MANIFOLDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FUNCTIONAL GRADE, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FUNCTIONAL GRADE, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY GENERAL TRANSFER TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY GENERAL TRANSFER TUBING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY HIGH-PRESSURE TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY HIGH-PRESSURE TUBING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PUMP GRADE TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PUMP GRADE TUBING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER (ID) / SIZE CLASS, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER (ID) / SIZE CLASS, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LARGE-BORE/TRANSFER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LARGE-BORE/TRANSFER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MICRO-FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MICRO-FLOW, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STANDARD BIOPROCESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STANDARD BIOPROCESS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SIZE SPECIFICATIONS, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SIZE SPECIFICATIONS, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LARGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LARGE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MEDIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MEDIUM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MICROBORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MICROBORE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SMALL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SMALL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LENGTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LENGTH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BULK COILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BULK COILS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRE-CUT LENGTHS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRE-CUT LENGTHS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LENGTH, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY WALL THICKNESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY WALL THICKNESS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STANDARD WALL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STANDARD WALL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY THICK WALL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY THICK WALL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY THIN WALL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY THIN WALL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY WALL THICKNESS, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY WALL THICKNESS, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY CLEANROOM PACKAGED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY CLEANROOM PACKAGED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY GAMMA-STERILIZED DOUBLE-BAGGED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY GAMMA-STERILIZED DOUBLE-BAGGED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY NON-STERILE BULK PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY NON-STERILE BULK PACKAGING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRE-ASSEMBLED STERILE MANIFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRE-ASSEMBLED STERILE MANIFOLDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILTRATION & CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILTRATION & CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY HARVEST & CLARIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY HARVEST & CLARIFICATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILL-FINISH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILL-FINISH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STERILE SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STERILE SAMPLING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILL-FINISH, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILL-FINISH, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MEDIA & BUFFER PREPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MEDIA & BUFFER PREPARATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SEED TRAIN & BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SEED TRAIN & BIOREACTORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UTILITIES & TRANSFER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UTILITIES & TRANSFER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PERISTALTIC PUMPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PERISTALTIC PUMPING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 123. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STORAGE & FREEZING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STORAGE & FREEZING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 125. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TRANSFER & DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TRANSFER & DISTRIBUTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 127. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UTILITIES & TRANSFER, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UTILITIES & TRANSFER, 2025-2030 (USD MILLION)
  • TABLE 129. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 131. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 133. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BIOPHARMA & BIOTECH MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BIOPHARMA & BIOTECH MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 135. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY EMERGING BIOTECH FIRMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY EMERGING BIOTECH FIRMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 137. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 139. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BIOPHARMA & BIOTECH MANUFACTURERS, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BIOPHARMA & BIOTECH MANUFACTURERS, 2025-2030 (USD MILLION)
  • TABLE 141. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY CELL & GENE THERAPY DEVELOPERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY CELL & GENE THERAPY DEVELOPERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 143. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 145. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS (CMOS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS (CMOS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 147. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 149. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 151. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DISTRIBUTORS & WHOLESALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DISTRIBUTORS & WHOLESALERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 153. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 155. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 157. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TUBING TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TUBING TYPE, 2025-2030 (USD MILLION)
  • TABLE 159. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
  • TABLE 161. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FUNCTIONAL GRADE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FUNCTIONAL GRADE, 2025-2030 (USD MILLION)
  • TABLE 163. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER (ID) / SIZE CLASS, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER (ID) / SIZE CLASS, 2025-2030 (USD MILLION)
  • TABLE 165. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SIZE SPECIFICATIONS, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SIZE SPECIFICATIONS, 2025-2030 (USD MILLION)
  • TABLE 167. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER, 2025-2030 (USD MILLION)
  • TABLE 169. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LENGTH, 2025-2030 (USD MILLION)
  • TABLE 171. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY WALL THICKNESS, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY WALL THICKNESS, 2025-2030 (USD MILLION)
  • TABLE 173. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
  • TABLE 175. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 177. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 179. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILL-FINISH, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILL-FINISH, 2025-2030 (USD MILLION)
  • TABLE 181. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 183. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UTILITIES & TRANSFER, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UTILITIES & TRANSFER, 2025-2030 (USD MILLION)
  • TABLE 185. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 187. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BIOPHARMA & BIOTECH MANUFACTURERS, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BIOPHARMA & BIOTECH MANUFACTURERS, 2025-2030 (USD MILLION)
  • TABLE 189. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 191. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 193. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TUBING TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TUBING TYPE, 2025-2030 (USD MILLION)
  • TABLE 197. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
  • TABLE 198. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
  • TABLE 199. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FUNCTIONAL GRADE, 2018-2024 (USD MILLION)
  • TABLE 200. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FUNCTIONAL GRADE, 2025-2030 (USD MILLION)
  • TABLE 201. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER (ID) / SIZE CLASS, 2018-2024 (USD MILLION)
  • TABLE 202. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER (ID) / SIZE CLASS, 2025-2030 (USD MILLION)
  • TABLE 203. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SIZE SPECIFICATIONS, 2018-2024 (USD MILLION)
  • TABLE 204. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SIZE SPECIFICATIONS, 2025-2030 (USD MILLION)
  • TABLE 205. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 206. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER, 2025-2030 (USD MILLION)
  • TABLE 207. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LENGTH, 2025-2030 (USD MILLION)
  • TABLE 209. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY WALL THICKNESS, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY WALL THICKNESS, 2025-2030 (USD MILLION)
  • TABLE 211. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
  • TABLE 213. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 215. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 216. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 217. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILL-FINISH, 2018-2024 (USD MILLION)
  • TABLE 218. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILL-FINISH, 2025-2030 (USD MILLION)
  • TABLE 219. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 220. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 221. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UTILITIES & TRANSFER, 2018-2024 (USD MILLION)
  • TABLE 222. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UTILITIES & TRANSFER, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BIOPHARMA & BIOTECH MANUFACTURERS, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BIOPHARMA & BIOTECH MANUFACTURERS, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 231. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TUBING TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TUBING TYPE, 2025-2030 (USD MILLION)
  • TABLE 235. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
  • TABLE 236. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
  • TABLE 237. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FUNCTIONAL GRADE, 2018-2024 (USD MILLION)
  • TABLE 238. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FUNCTIONAL GRADE, 2025-2030 (USD MILLION)
  • TABLE 239. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER (ID) / SIZE CLASS, 2018-2024 (USD MILLION)
  • TABLE 240. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER (ID) / SIZE CLASS, 2025-2030 (USD MILLION)
  • TABLE 241. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SIZE SPECIFICATIONS, 2018-2024 (USD MILLION)
  • TABLE 242. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SIZE SPECIFICATIONS, 2025-2030 (USD MILLION)
  • TABLE 243. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 244. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER, 2025-2030 (USD MILLION)
  • TABLE 245. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 246. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LENGTH, 2025-2030 (USD MILLION)
  • TABLE 247. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY WALL THICKNESS, 2018-2024 (USD MILLION)
  • TABLE 248. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY WALL THICKNESS, 2025-2030 (USD MILLION)
  • TABLE 249. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 250. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
  • TABLE 251. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 253. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 254. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 255. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILL-FINISH, 2018-2024 (USD MILLION)
  • TABLE 256. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILL-FINISH, 2025-2030 (USD MILLION)
  • TABLE 257. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 258. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 259. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UTILITIES & TRANSFER, 2018-2024 (USD MILLION)
  • TABLE 260. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UTILITIES & TRANSFER, 2025-2030 (USD MILLION)
  • TABLE 261. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 263. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BIOPHARMA & BIOTECH MANUFACTURERS, 2018-2024 (USD MILLION)
  • TABLE 264. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY BIOPHARMA & BIOTECH MANUFACTURERS, 2025-2030 (USD MILLION)
  • TABLE 265. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 267. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 269. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TUBING TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY TUBING TYPE, 2025-2030 (USD MILLION)
  • TABLE 271. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
  • TABLE 272. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
  • TABLE 273. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FUNCTIONAL GRADE, 2018-2024 (USD MILLION)
  • TABLE 274. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FUNCTIONAL GRADE, 2025-2030 (USD MILLION)
  • TABLE 275. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER (ID) / SIZE CLASS, 2018-2024 (USD MILLION)
  • TABLE 276. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER (ID) / SIZE CLASS, 2025-2030 (USD MILLION)
  • TABLE 277. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SIZE SPECIFICATIONS, 2018-2024 (USD MILLION)
  • TABLE 278. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY SIZE SPECIFICATIONS, 2025-2030 (USD MILLION)
  • TABLE 279. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER, 2018-2024 (USD MILLION)
  • TABLE 280. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY INNER DIAMETER, 2025-2030 (USD MILLION)
  • TABLE 281. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 282. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY LENGTH, 2025-2030 (USD MILLION)
  • TABLE 283. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY WALL THICKNESS, 2018-2024 (USD MILLION)
  • TABLE 284. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY WALL THICKNESS, 2025-2030 (USD MILLION)
  • TABLE 285. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 286. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
  • TABLE 287. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 289. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 290. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 291. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILL-FINISH, 2018-2024 (USD MILLION)
  • TABLE 292. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY FILL-FINISH, 2025-2030 (USD MILLION)
  • TABLE 293. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 294. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 295. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UTILITIES & TRANSFER, 2018-2024 (USD MILLION)
  • TABLE 296. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY UTILITIES & TRANSFER, 2025-2030 (USD MILLION)

TABLE 297